Sanjivani Paranterals (BOM:531569) Cyclically Adjusted Revenue per Share: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531569 Sanjivani Paranterals Ltd BOM:531569
73 GF Score
Price ₹193.40
GF Value ₹228.65
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Sanjivani Paranterals Cyclically Adjusted Revenue per Share?

Sanjivani Paranterals BOM:531569 +1.34% 73 Cyclically Adjusted Revenue per Share is ₹0.00 as of Jun. 2026. GuruFocus rates BOM:531569 with a GF Score™ of 73/100 and a GF Value™ of ₹228.65 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sanjivani Paranterals's adjusted revenue per share for the three months ended in Jun. 2026 was ₹20.057. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sanjivani Paranterals's average Cyclically Adjusted Revenue Growth Rate was -29.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -27.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -22.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sanjivani Paranterals was -18.00% per year. The lowest was -27.20% per year. And the median was -23.30% per year.

As of today (2026-08-24), Sanjivani Paranterals's current stock price is ₹193.40. Sanjivani Paranterals's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹0.00. Sanjivani Paranterals's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sanjivani Paranterals was 4.36. The lowest was 0.05. And the median was 1.00.


Sanjivani Paranterals  (BOM:531569) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sanjivani Paranterals was 4.36. The lowest was 0.05. And the median was 1.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sanjivani Paranterals Cyclically Adjusted Revenue per Share Related Terms


Sanjivani Paranterals Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sanjivani Paranterals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanjivani Paranterals Cyclically Adjusted Revenue per Share Chart

Sanjivani Paranterals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.51 139.25 104.68 76.54 53.79

Sanjivani Paranterals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.18 58.32 53.97 53.79 0.00

BOM:531569 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanjivani Paranterals Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sanjivani Paranterals's Cyclically Adjusted PS Ratio falls into.


BOM:531569
73GF Score
Sanjivani Paranterals Ltd BOM:531569
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanjivani Paranterals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sanjivani Paranterals's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=20.057/167.3573*167.3573
=20.057

Current CPI (Jun. 2026) = 167.3573.

Sanjivani Paranterals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 10.706 105.961 16.909
201612 16.535 105.196 26.306
201703 11.467 105.196 18.243
201706 8.990 107.109 14.047
201709 7.952 109.021 12.207
201712 6.930 109.404 10.601
201803 6.570 109.786 10.015
201806 9.463 111.317 14.227
201809 9.710 115.142 14.113
201812 14.285 115.142 20.763
201903 17.425 118.202 24.671
201906 6.386 120.880 8.841
201909 9.827 123.175 13.352
201912 4.983 126.235 6.606
202003 5.927 124.705 7.954
202006 8.388 127.000 11.053
202009 13.934 130.118 17.922
202012 8.096 130.889 10.352
202103 8.012 131.771 10.176
202106 9.525 134.084 11.889
202109 9.746 135.847 12.007
202112 7.604 138.161 9.211
202203 4.993 138.822 6.019
202206 9.935 142.347 11.681
202209 8.383 144.661 9.698
202212 9.091 145.763 10.438
202303 7.844 146.865 8.939
202306 12.582 150.280 14.012
202309 14.035 151.492 15.505
202312 14.952 152.924 16.363
202403 7.246 153.035 7.924
202406 14.098 155.789 15.145
202409 15.478 157.882 16.407
202412 14.804 158.323 15.649
202503 13.390 157.552 14.223
202506 14.577 159.755 15.271
202509 12.579 162.289 12.972
202512 17.563 163.281 18.001
202603 11.804 164.272 12.026
202606 20.057 167.357 20.057

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹0.00 mean?
Sanjivani Paranterals (BOM:531569) has a Cyclically Adjusted Revenue per Share of ₹0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sanjivani Paranterals and its competitors.
Is Sanjivani Paranterals' Cyclically Adjusted Revenue per Share too high?
Sanjivani Paranterals' current Cyclically Adjusted Revenue per Share is ₹0.00. Overall, Sanjivani Paranterals has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sanjivani Paranterals' Cyclically Adjusted Revenue per Share compare to ZTS?
Sanjivani Paranterals' Cyclically Adjusted Revenue per Share of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sanjivani Paranterals and its competitors. Sanjivani Paranterals's current Cyclically Adjusted Revenue per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanjivani Paranterals stock overvalued right now?
Based on GuruFocus' analysis, Sanjivani Paranterals (BOM:531569) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.65, compared to a current price of ₹193.40 — trading 15.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹0.00. Sanjivani Paranterals' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sanjivani Paranterals (BOM:531569), the current Cyclically Adjusted Revenue per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanjivani Paranterals (BOM:531569) Overvalued in 2026?

Based on GuruFocus' analysis, Sanjivani Paranterals stock appears to be undervalued. The current stock price of ₹193.40 is trading 15.4% below its estimated GF Value™ of ₹228.65. GuruFocus considers Sanjivani Paranterals to be Modestly Undervalued.

Key valuation signals for BOM:531569:

  • Cyclically Adjusted Revenue per Share: ₹0.00
  • GF Value™: ₹228.65 vs. price of ₹193.40 (15.4% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the BOM:531569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanjivani Paranterals Business Description

Address Asha Nagar Park Road, 1202, B-Wing, O2 Business Commercial Park, Mulund (West), Mumbai, MH, IND, 400080
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.
73GF Score

Get the complete analysis for BOM:531569

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹193.40
Price
₹228.65
GF Value